32
Beleave Completes First Harvest at Hamilton Facility
Toronto , ON – September 28 th , 2017 - Beleave Inc . (" Beleave " or the " Company ") ( CSE : BE ; OTCQX : BLEVF ) is pleased to announce that it has completed harvesting and drying its first two lots of cannabis at its Hamilton , Ontario facility ; a process required by Health Canada prior to requesting a sales license . The Company will apply for a license to sell dried cannabis after it has received confirmation from a third-party laboratory that quality assurance testing results are compliant with the Access to Cannabis for Medical Purposes Regulations .
" We are extremely pleased with everything having gone according to what we expected . Furthermore , we have developed quite a bit of knowledge with respect to the strains we are cultivating , and are continually fine tuning our growing practices to optimize these strains for large scale commercial production ", commented Beleave CEO , Roger Ferreira . " Our facility is now in full production , with plants at each stage of the growth cycle . We anticipate a quick turnaround time between crops moving forward ."
About Beleave Beleave Inc . is a biotech company and Beleave ' s wholly-owned subsidiary Beleave Kannabis Corp . ( formerly First Access Medical Inc .) is a licensed producer pursuant to the ACMPR . Beleave ' s purpose-built facility is located near Hamilton , Ontario .
For further information please contact :
Sebastian de Kloet Phone : ( 905 ) 979 - 5173 Email : sebastian @ beleave . com beleave . com
Forward-Looking Statements
This news release contains " forward-looking information " within the meaning of applicable securities law (" forward-looking statements "). The use of any of the words " plan ", " anticipate ", " continue ", " estimate ", " expect ", " may ", " will ", " project ", " should ", " believe " and other similar words , or statements that certain events or conditions " may " or " will " occur are intended to identify forward-looking information . These statements are only predictions . Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable , undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct . These risks and uncertainties include , but are not limited to , the Company ' s ability to satisfy the conditions associated with its cultivation licence , the Company ' s ability to obtain a sales licence and the related timing considerations , the availability of further financing , consumer interest in its products , competition , regulation , operational and technological risks , and anticipated and unanticipated costs and delays . Since forward-looking information addresses future events and conditions , by its very nature it involves inherent risks and uncertainties . This information speak only as of the date of this news release . Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company ' s disclosure documents , which can be found under the Company ' s profile on www . sedar . com .
48
PRESS RELEASE